New York 2025-2026 Regular Session

New York Assembly Bill A01937

Introduced
1/14/25  
Refer
1/14/25  

Caption

Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.

Companion Bills

NY S05260

Same As Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.

Previously Filed As

NY S05260

Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.

NY A06518

Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.

NY A2744

Requires prescriptions for certain patients to include patients' weight.

NY HB2694

Enacting the opioid patients right to know act to require the disclosure of the risks associated with prescribed opioid use.

NY HB1200

Opioid prescriptions.

NY S518

Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

NY A09010

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

NY S06758

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

NY HB3472

OPIOID PATIENTS RIGHT TO KNOW

NY S00493

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

Similar Bills

No similar bills found.